These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3840365)

  • 21. Ocular irritative response to YAG laser capsulotomy in rabbits: release of calcitonin gene-related peptide and effects of methysergide.
    Krootila K; Oksala O; von Dickhoff K; Wimalawansa SJ; MacIntyre I; Uusitalo H
    Curr Eye Res; 1992 Apr; 11(4):307-14. PubMed ID: 1326426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intraocular lens fixation on acute intraocular pressure rise after neodymium-YAG laser capsulotomy.
    Anand N; Tole DM; Morrell AJ
    Eye (Lond); 1996; 10 ( Pt 4)():509-13. PubMed ID: 8944108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAG capsulotomy and IOP rise.
    Clorfeine GS; Parker WT
    Ophthalmic Surg; 1984 Jul; 15(7):610-1. PubMed ID: 6472790
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of 1% sodium hyaluronate in anterior capsulotomy with the neodymium:YAG laser in patients with diseased cornea.
    Alpar JJ
    J Cataract Refract Surg; 1986 Nov; 12(6):658-61. PubMed ID: 3783473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; YĆ¼cel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of IOP-rise following Nd-YAG laser capsulotomy with pre-operative timolol eye-drops and 1 tablet acetazolamide 250 mg systematically.
    Boen-Tan TN; Stilma JS
    Doc Ophthalmol; 1986 Dec; 64(1):59-67. PubMed ID: 3582103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of neodymium: YAG laser on sodium hyaluronate in vitro as a model for postcapsulotomy intraocular pressure change.
    Adams EA; Verstraeten TC; Friberg TR; Rehkopf PG; Stefanovic-Racic M
    J Cataract Refract Surg; 1996; 22(6):748-51. PubMed ID: 8844390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreoretinal changes associated with rise in intraocular pressure after Nd:YAG capsulotomy.
    Schubert HD
    Ophthalmic Surg; 1987 Jan; 18(1):19-22. PubMed ID: 3561934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed increased intraocular pressure after Nd:YAG laser posterior capsulotomy in a patient treated with apraclonidine.
    Nesher R; Kolker AE
    Am J Ophthalmol; 1990 Jul; 110(1):94-5. PubMed ID: 2195897
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute angle-closure glaucoma caused by vitreous prolapse after neodymium:YAG posterior capsulotomy.
    Mihora LD; Bowers PJ; Blank NM
    J Cataract Refract Surg; 2004 Nov; 30(11):2445-7. PubMed ID: 15519106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neodymium-YAG laser posterior capsulotomy for the treatment of aphakic and pseudophakic pupillary block.
    Tomey KF; Traverso CE
    Am J Ophthalmol; 1987 Nov; 104(5):502-7. PubMed ID: 3674184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraocular pressure changes after neodymium-YAG laser capsulotomy in eyes pretreated with timolol.
    Migliori ME; Beckman H; Channell MM
    Arch Ophthalmol; 1987 Apr; 105(4):473-5. PubMed ID: 3566598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary surgical and neodymium-YAG laser discissions.
    Liesegang TJ; Bourne WM; Ilstrup DM
    Am J Ophthalmol; 1985 Oct; 100(4):510-9. PubMed ID: 3840334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neodymium: YAG lasers. An FDA report.
    Stark WJ; Worthen D; Holladay JT; Murray G
    Ophthalmology; 1985 Feb; 92(2):209-12. PubMed ID: 3982799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical clonidine.
    Loewenstein A; Varssano D; Lazar M; Geyer O
    Acta Ophthalmol (Copenh); 1991 Aug; 69(4):462-5. PubMed ID: 1750315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neodymium-YAG laser for posterior capsulotomy.
    Terry AC; Stark WJ; Maumenee AE; Fagadau W
    Am J Ophthalmol; 1983 Dec; 96(6):716-20. PubMed ID: 6660258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of post-vitrectomy persistent vitreous hemorrhage in pseudophakic eyes.
    Landers MB; Perraki AD
    Am J Ophthalmol; 2003 Dec; 136(6):989-93. PubMed ID: 14644207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nd-YAG laser capsulotomy in intraocular lenses with reversed optics].
    Wizemann A; Jacobi KW
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):175-9. PubMed ID: 6727229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal changes in posterior capsulotomy dimensions following neodymium:YAG laser discission.
    Capone A; Rehkopf PG; Warnicki JW; Stuart JC
    J Cataract Refract Surg; 1990 Jul; 16(4):451-6. PubMed ID: 2380925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.